Cost-effectiveness of pertuzumab and trastuzumab as a first-line treatment of HER2-positive metastatic breast cancer in China
@article{APM81088,
author = {Hao Wang and Ye Wang and Ruixue Gong and Yuyu Geng and Li Li},
title = {Cost-effectiveness of pertuzumab and trastuzumab as a first-line treatment of HER2-positive metastatic breast cancer in China},
journal = {Annals of Palliative Medicine},
volume = {10},
number = {11},
year = {2021},
keywords = {},
abstract = {},
issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/81088}
}